Dyne Therapeutics stock tumbles following trial data
Investing.com -- Shares of Dyne Therapeutics, Inc. (Nasdaq: DYN) plummeted 25% as the biotechnology firm reported early trial data for its experimental therapy for myotonic dystrophy type 1 (DM1)...
Absci stock soars on AMD partnership and investment
Investing.com -- Shares of Absci Corporation (NASDAQ: ABSI) soared 50% following the announcement of a strategic collaboration and a $20 million investment from AMD (NASDAQ: AMD ). The...
Morning Bid: Pre-Trump trades lift US yields, yuan shaky
A look at the day ahead in U.S. and global markets from Mike Dolan The first full trading week of 2025 kicks off with markets positioning for the Jan. 20 inauguration of Donald Trump as Pre...
